Preferred Label : Percutaneous Aortic Valve Replacement;
NCIt definition : A procedure performed to replace a narrowed and calcified aortic valve in patients
unable to withstand open chest surgery. A bioprosthesis is advanced through the vessels
with a catheter up to the diseased native aortic valve. Once the catheter is positioned
in the opening of the aortic valve it releases the bioprosthesis at the mid part of
the aortic valve.;
Origin ID : C80448;
UMLS CUI : C2825191;
Semantic type(s)
- procedure_has_completely_excised_anatomy
- procedure_has_target_anatomy
https://ansm.sante.fr/informations-de-securite/rivaroxaban-xarelto-essai-clinique-arrete-prematurement-chez-des-patients-ayant-beneficie-dun-remplacement-valvulaire-aortique-percutane
2018
false
false
false
France
French
Rivaroxaban
Percutaneous Aortic Valve Replacement
early termination of clinical trials
Transcatheter Aortic Valve Replacement
thromboembolism
chemoprevention
pharmacovigilance note
guidelines for drug use
rivaroxaban
drug therapy, combination
Factor Xa Inhibitors
thromboembolism
hemorrhage
product surveillance, postmarketing
---
